Go Pro

LifeStance Health Group (LFST) Competitors

LifeStance Health Group logo
$10.26 -0.28 (-2.66%)
Closing price 04:00 PM Eastern
Extended Trading
$10.25 -0.01 (-0.10%)
As of 07:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LFST vs. BTSG, FMS, PACS, HIMS, and BLLN

Should you buy LifeStance Health Group stock or one of its competitors? MarketBeat compares LifeStance Health Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with LifeStance Health Group include BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), PACS Group (PACS), Hims & Hers Health (HIMS), and Billiontoone (BLLN).

How does LifeStance Health Group compare to BrightSpring Health Services?

LifeStance Health Group (NASDAQ:LFST) and BrightSpring Health Services (NASDAQ:BTSG) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

In the previous week, BrightSpring Health Services had 18 more articles in the media than LifeStance Health Group. MarketBeat recorded 22 mentions for BrightSpring Health Services and 4 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 1.39 beat BrightSpring Health Services' score of 0.80 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
7 Very Positive mention(s)
1 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

85.5% of LifeStance Health Group shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

BrightSpring Health Services has a net margin of 2.55% compared to LifeStance Health Group's net margin of 1.55%. BrightSpring Health Services' return on equity of 16.73% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group1.55% 1.56% 1.07%
BrightSpring Health Services 2.55%16.73%5.24%

BrightSpring Health Services has higher revenue and earnings than LifeStance Health Group. BrightSpring Health Services is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.42B2.79$9.66M$0.06171.00
BrightSpring Health Services$12.91B0.96$190.67M$1.6637.77

LifeStance Health Group currently has a consensus price target of $11.50, suggesting a potential upside of 12.09%. BrightSpring Health Services has a consensus price target of $70.71, suggesting a potential upside of 12.78%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, analysts plainly believe BrightSpring Health Services is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73
BrightSpring Health Services
0 Sell rating(s)
1 Hold rating(s)
18 Buy rating(s)
1 Strong Buy rating(s)
3.00

LifeStance Health Group has a beta of 1.14, meaning that its stock price is 14% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.88, meaning that its stock price is 88% more volatile than the broader market.

Summary

BrightSpring Health Services beats LifeStance Health Group on 11 of the 16 factors compared between the two stocks.

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, media sentiment, valuation, analyst recommendations and profitability.

Fresenius Medical Care AG & Co. KGaA currently has a consensus target price of $23.95, indicating a potential downside of 0.42%. LifeStance Health Group has a consensus target price of $11.50, indicating a potential upside of 12.09%. Given LifeStance Health Group's stronger consensus rating and higher possible upside, analysts clearly believe LifeStance Health Group is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.55
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Fresenius Medical Care AG & Co. KGaA had 9 more articles in the media than LifeStance Health Group. MarketBeat recorded 13 mentions for Fresenius Medical Care AG & Co. KGaA and 4 mentions for LifeStance Health Group. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.86 beat LifeStance Health Group's score of 1.39 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
7 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Very Positive
LifeStance Health Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to LifeStance Health Group's net margin of 1.55%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.88% 8.90% 4.05%
LifeStance Health Group 1.55%1.56%1.07%

Fresenius Medical Care AG & Co. KGaA has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.14, suggesting that its stock price is 14% more volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than LifeStance Health Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.58$1.11B$1.9012.66
LifeStance Health Group$1.42B2.79$9.66M$0.06171.00

Summary

LifeStance Health Group beats Fresenius Medical Care AG & Co. KGaA on 9 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to PACS Group?

PACS Group (NYSE:PACS) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, media sentiment, profitability, risk, dividends, earnings and institutional ownership.

PACS Group presently has a consensus price target of $50.60, indicating a potential upside of 13.07%. LifeStance Health Group has a consensus price target of $11.50, indicating a potential upside of 12.09%. Given PACS Group's higher probable upside, equities research analysts plainly believe PACS Group is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

PACS Group has higher revenue and earnings than LifeStance Health Group. PACS Group is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.34$191.54M$1.5628.69
LifeStance Health Group$1.42B2.79$9.66M$0.06171.00

85.5% of LifeStance Health Group shares are owned by institutional investors. 70.1% of PACS Group shares are owned by company insiders. Comparatively, 3.5% of LifeStance Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, PACS Group had 7 more articles in the media than LifeStance Health Group. MarketBeat recorded 11 mentions for PACS Group and 4 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 1.39 beat PACS Group's score of 1.20 indicating that LifeStance Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
8 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LifeStance Health Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

PACS Group has a beta of -0.08, suggesting that its stock price is 108% less volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.14, suggesting that its stock price is 14% more volatile than the broader market.

PACS Group has a net margin of 4.49% compared to LifeStance Health Group's net margin of 1.55%. PACS Group's return on equity of 26.47% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.49% 26.47% 4.36%
LifeStance Health Group 1.55%1.56%1.07%

Summary

PACS Group beats LifeStance Health Group on 9 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to Hims & Hers Health?

LifeStance Health Group (NASDAQ:LFST) and Hims & Hers Health (NYSE:HIMS) are both mid-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk.

85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

LifeStance Health Group has a beta of 1.14, indicating that its share price is 14% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.4, indicating that its share price is 140% more volatile than the broader market.

Hims & Hers Health has higher revenue and earnings than LifeStance Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.42B2.79$9.66M$0.06171.00
Hims & Hers Health$2.35B3.16$128.37M-$0.09N/A

In the previous week, Hims & Hers Health had 24 more articles in the media than LifeStance Health Group. MarketBeat recorded 28 mentions for Hims & Hers Health and 4 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 1.39 beat Hims & Hers Health's score of 0.24 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hims & Hers Health
4 Very Positive mention(s)
3 Positive mention(s)
13 Neutral mention(s)
5 Negative mention(s)
3 Very Negative mention(s)
Neutral

LifeStance Health Group has a net margin of 1.55% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group1.55% 1.56% 1.07%
Hims & Hers Health -0.56%6.10%1.52%

LifeStance Health Group presently has a consensus price target of $11.50, indicating a potential upside of 12.09%. Hims & Hers Health has a consensus price target of $31.43, indicating a potential downside of 2.02%. Given LifeStance Health Group's stronger consensus rating and higher probable upside, analysts clearly believe LifeStance Health Group is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73
Hims & Hers Health
1 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.19

Summary

LifeStance Health Group beats Hims & Hers Health on 9 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to Billiontoone?

LifeStance Health Group (NASDAQ:LFST) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation.

LifeStance Health Group has a net margin of 1.55% compared to Billiontoone's net margin of 0.00%. LifeStance Health Group's return on equity of 1.56% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group1.55% 1.56% 1.07%
Billiontoone N/A N/A N/A

LifeStance Health Group currently has a consensus price target of $11.50, suggesting a potential upside of 12.09%. Billiontoone has a consensus price target of $126.00, suggesting a potential downside of 11.59%. Given LifeStance Health Group's stronger consensus rating and higher possible upside, equities analysts clearly believe LifeStance Health Group is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

LifeStance Health Group has higher revenue and earnings than Billiontoone. LifeStance Health Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.42B2.79$9.66M$0.06171.00
Billiontoone$305.11M21.48$7.45M$0.55259.13

85.5% of LifeStance Health Group shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by insiders. Comparatively, 50.2% of Billiontoone shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Billiontoone had 4 more articles in the media than LifeStance Health Group. MarketBeat recorded 8 mentions for Billiontoone and 4 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 1.39 beat Billiontoone's score of 0.69 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
3 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

LifeStance Health Group beats Billiontoone on 10 of the 15 factors compared between the two stocks.

Get LifeStance Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFST vs. The Competition

MetricLifeStance Health GroupHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$3.98B$9.88B$6.80B$13.02B
Dividend YieldN/A2.54%2.60%10.03%
P/E Ratio171.0025.64279.7225.54
Price / Sales2.794.84648.71115.96
Price / Cash62.3026.4428.6434.82
Price / Book2.625.1911.126.36
Net Income$9.66M$312.25M$3.48B$347.58M
7 Day Performance-8.72%-0.81%2.59%3.17%
1 Month Performance-8.96%-0.79%-2.79%-2.06%
1 Year Performance163.08%25.04%64.29%21.19%

LifeStance Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFST
LifeStance Health Group
4.4843 of 5 stars
$10.26
-2.7%
$11.50
+12.1%
+178.1%$3.98B$1.42B171.0010,961
BTSG
BrightSpring Health Services
4.8523 of 5 stars
$72.46
+0.7%
$70.12
-3.2%
+207.9%$14.30B$13.65B51.3923,500
FMS
Fresenius Medical Care AG & Co. KGaA
3.9128 of 5 stars
$24.76
-0.5%
$23.95
-3.3%
+1.0%$13.30B$22.20B13.031,488
PACS
PACS Group
3.8391 of 5 stars
$46.97
-0.2%
$50.60
+7.7%
+320.1%$7.43B$5.43B30.1147,455
HIMS
Hims & Hers Health
2.2534 of 5 stars
$29.40
-2.8%
$31.43
+6.9%
-50.7%$6.81B$2.37BN/A2,442

Related Companies and Tools


This page (NASDAQ:LFST) was last updated on 8/4/2026 by MarketBeat.com Staff.
From Our Partners